Correlagen to Launch Genetic Cardiovascular Disease Assay on Helicos Platform This Month

The assay, Correlagen Diagnostics' first to run on a next-generation sequencer, will cover approximately 300 genes associated with hereditary cardiovascular disease. Going forward, the genetic testing company plans to use the Helicos system for other assays in the areas of endocrinology, neuropsychiatry, and immunology.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.